Independent news. Trusted by Texans. Support us. By Carlos Nogueras Ramos and Jayme Lozano Carver Sept. 11, 2025 Thirty stations must figure out how to make up for the loss of at least $17.7 million ...

Live streaming and on-demand. Anywhere and anytime.

Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA submission is ...